Results 151 to 160 of about 50,714 (241)

Papillary Thyroid Microcarcinoma: Diagnostic and Histopathological Insights From a Case Report. [PDF]

Cureus
Malhotra S, Rana MN, Yadav Y, Subudhi G, Arif M.   +4 more
europepmc   +1 more source

Experience over tools: does the use of magnifying loupes reduce the incidence of transient postoperative hypocalcemia after total thyroidectomy with central neck dissection? - a single-centre prospective randomized study. [PDF]

Front Endocrinol (Lausanne)
Sielski W, Osęka T, Antolak A, Kaska Ł, Żawrocki A, Kucewicz MT, Dymecki D.   +6 more
europepmc   +1 more source

Renal Phosphate Reabsorption in Humans Depends on at Least Three Distinct Transporters Unlike in Mice

Acta Physiologica, Volume 242, Issue 8, August 2026.
ABSTRACT Aim Kidney excretion of phosphate is the gatekeeper of systemic phosphate homeostasis as evident from inborn and acquired diseases. Renal phosphate transporters are a promising target for phosphate‐lowering drugs, but molecular details of human kidney phosphate handling are largely unknown.
Ashley L. Fernandes, Laurine Lang, Jürgen Klar, Anja Giese, Alexander Ehrmann, Rupert Busch, Hannah Auwerx, Christoph Daniel, Nati Hernando, Isabel Rubio‐Aliaga, Carsten A. Wagner   +10 more
wiley   +1 more source

Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management. [PDF]

Med J Aust
Wootton E, De Sousa SMC, Prince RL, McLeod DSA, Pattison DA, Grossmann M.   +5 more
europepmc   +1 more source

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors

British Journal of Pharmacology, Volume 183, Issue 16, Page 4512-4531, August 2026.
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley   +1 more source

Ectopic parathyroid carcinoma coexisting with Graves' disease: A case report and literature review. [PDF]

Medicine (Baltimore)
Li GZ, Li N, Wang ZP, Tang WY, Zhao ZS.
europepmc   +1 more source

Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights

Cancer Science, Volume 117, Issue 8, Page 2029-2039, August 2026.
Schematic overview of progression from differentiated thyroid carcinoma (DTC) to anaplastic thyroid carcinoma (ATC). ATC primarily develops via two pathways: the BRAF p.V600E‐mutated papillary thyroid carcinoma (PTC) pathway and the RAS‐mutated pathway. The origin and progression of BRAF/RAS‐wildtype ATC remain unclear.
Toru Odate, Tetsuo Kondo
wiley   +1 more source

Elevated parathyroid hormone levels in normocalcemic patients after parathyroidectomy for primary hyperparathyroidism: what risk factors should be considered? [PDF]

BMC Endocr Disord
Yang J, He Z, Zhou P, Lu X, Weng W, Ding C, Wang H, Su X.   +7 more
europepmc   +1 more source

Vitamin D Supplementation to Prevent Post‐Thyroidectomy Hypocalcemia

Clinical Endocrinology, Volume 105, Issue 2, Page 259-266, August 2026.
ABSTRACT Objective Hypocalcemia is the most common complication following thyroidectomy. Previous studies yielded inconsistent results on whether vitamin D3 prevents postoperative hypocalcemia and were conducted in non‐European countries with different dietary habits and baseline vitamin D levels.
Jeresa I. A. Willems, Daan J. L. van Twist, Kristy M. Pickwell, Patrick L. H. van Battum, Rutgert Bianchi, Annette M. Pijnenburg, James van Bastelaar, Marco Medici, Robin P. Peeters, Roderick F.A. Tummers‐de Lind van Wijngaarden   +9 more
wiley   +1 more source

Primary Hyperparathyroidism in a Pregnant Immigrant Facing Healthcare Hurdles: A Case Report. [PDF]

Case Rep Obstet Gynecol
McCrary R, Huang T, Worley M, Daugherty R, Stisher A.   +4 more
europepmc   +1 more source